Skip to content
2000
Volume 5, Issue 5
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Heparin is a biogenic anionic charged sulfated polysaccharide that has a range of desired activities including inhibition of tumor metastasis and inhibition of restenosis. However, its clinical use is limited to treating blood-clotting disorders. Anionic macromolecules called heparinoids have been investigated with the objective of developing heparin-like molecules with reduced anti-coagulant activity and selective antimetastasis and anti-restenosis activity. This mini-review summarizes the synthesis and biological activity of the main synthetic heparinoids reported in the past three decades.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557053765538
2005-05-01
2025-08-16
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557053765538
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test